Endocrine Pathology

, Volume 13, Issue 2, pp 99–110 | Cite as

N-cadherin expression in adrenal tumors: Upregulation in malignant pheochromocytoma and downregulation in adrenocortical carcinoma

  • Amir Khorram-Manesh
  • Håkan Ahlman
  • Svante Jansson
  • Ola Nilsson
Clinical Research


Cell adhesion molecules (CAMs) are important regulators of tumor growth. The aim of the present study was to evaluate the expression pattern of CAMs in adrenal tumors regarding origin (cortex vs medulla) and biologic behavior (benign vs malignant). Eighty-seven adrenal tumors were investigated by immunocytochemistry (ICC) using monoclonal antibodies against N-cadherin (NCAD), E-cadherin (ECAD), neural cell adhesion molecule (NCAM), and CD44. Western blotting was performed on 30 tumors using the same antibodies. Markers for proliferation (Ki-67) and catecholamine synthesis (tyrosine hydroxylase) were also analyzed in tumors by ICC. NCAD was expressed in 12/27 benign pheochromocytomas (BPCs) (12 familial cases), 8/8 malignant pheochromocytomas (MPCs), 28/30 adrenocortical adenomas, and 9/22 adrenocortical carcinomas. ECAD was expressed in 0/27 BPCs, 0/8 MPCs, 0/30 adrenocortical adenomas, and 2/22 adrenocortical carcinomas. NCAM was expressed in 26/27 BPCs, 7/8 MPCs, 21/30 adrenocrotical adenomas, and 17/22 adrenocortical carcinomas. CD44 was expressed in 23/27 BPCs, 6/8 MPCs, 7/30 adrenocortical adenomas, and 4/22 adrenocortical carcinomas. Both cortical and medullary adrenal tumors expressed NCAD, NCAM, and CD44 but were devoid of ECAD. The expression of CD44 and NCAM did not correlate with the malignant potential of tumors. NCAD was upregulated in MPCs, but downregulated in adrenocortical carcinoma. Thus, NCAD appears to be involved in the development of both cortical and medullary adrenal tumors.

Key Words

Adhesion molecules adrenal tumors N-cadherin E-cadherin pheochromocytomas 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Perl AK, Wilgenbus P, Dahl U, Semb H, Christofori G. A causal role of E-cadherin in the transition from adenoma to carcinoma. Nature 392:190–193, 1998.PubMedCrossRefGoogle Scholar
  2. 2.
    Perl AK, Dahl U, Christofori G. Reduced expression of neural cell adhesion molecule induces metastatic dissemination of pancreatic β tumor cells. Nat Med 5(3):286–291, 1999.PubMedCrossRefGoogle Scholar
  3. 3.
    Wallach-Dayan Shulamit B, Grabovsky V, Moll J, Sleeman J, Herrlich P, Alon R, Naor D. CD44-dependent lymphoma cell dissemination: a cell surface CD44, supports in vitro lymphoma cell rolling on hyaluronic acid substrate and its in vitro accumulation in the peripheral lymph nodes. J Cell Sci 114:3463–3477, 2001.Google Scholar
  4. 4.
    Langman J. Central nervous system. Medical embryology. 4th ed. Chapter 20. Baltimore: Williams & Wilkins, 1980; 351–353.Google Scholar
  5. 5.
    Dahia PLM, Grossman AB. The molecular pathogenesis of adrenal tumors. Endocr Relat Cancer 2(4):267–279, 1995.Google Scholar
  6. 6.
    Schröder S, Padberg BC, Achilles E, Klöppel G. Immunohistochemistry in adrenocortical tumors: a clinicomorphological study of 72 neoplasms. Virchows Arkiv A, Pathol Anat Histopathol 420:65–70, 1992.CrossRefGoogle Scholar
  7. 7.
    Saeger W. Pathology of adrenal neoplasm. Minerva Endocrinol 20:1–7, 1995.PubMedGoogle Scholar
  8. 8.
    Hough AJ, Hollifield JW, Page DL, Hartmann WH. Prognostic factors in adrenal cortical tumors. Am J Clin Pathol 72:390–399, 1979.PubMedGoogle Scholar
  9. 9.
    Weiss LM. Comparative histologic study of 43 metastasizing and nonmetastasizing adrenocortical tumors. Am J Surg Pathol 8:163–169, 1984.PubMedCrossRefGoogle Scholar
  10. 10.
    Medeiros LJ, Weiss LM. New Developments in the pathologic diagnosis of adrenal cortical neoplasms. Am J Clin Pathol 97:73–83, 1992.PubMedGoogle Scholar
  11. 11.
    Grant CS. Pheochromocytoma. In: Clark OH, Duh Q-Y, eds. Textbook of endocrine surgery. Chapter 65. Philadelphia: Saunders, 1997; 513–522.Google Scholar
  12. 12.
    Montresor E, Iacono C, Nifosi F, Serio G. Retroperitoneal Paragangliomas: role of immunohistochemistry in the diagnosis of malignancy and in assessment of prognosis. Eur J Surg 160:547–552, 1994.PubMedGoogle Scholar
  13. 13.
    John H, Ziegler WH, Hayri D, Jaeger P. Pheochromocytomas: can malignant potential be predicted? Urology 53(4):679–683, 1999.PubMedCrossRefGoogle Scholar
  14. 14.
    Komminoth P, Roth J, Schröder S, Saremaslani P, Heitz PU. Overlapping expression of immunohistochemical markers and synaptophysin mRNA in pheochromocytomas and adrenocortical carcinomas. Lab Invest 72(4):424–431, 1995.PubMedGoogle Scholar
  15. 15.
    McCluggage WG, Burton J, Maxwell P, Sloan JM. Immunohistochemical staining of normal, hyperplastic, and neoplastic adrenal cortex with a monoclonal antibody against alpha inhibin. Clin Pathol 51:114–116, 1998.Google Scholar
  16. 16.
    Miettinen M. Neuroendocrine differentiation in adrenocortical carcinoma: new immuno-histochemical findings supported by electron microscopy. Lab Invest 66:169–174, 1992.PubMedGoogle Scholar
  17. 17.
    Alsabeh R, Medeiros LJ, Weiss LM. Adrenal cortical tumors clinically mimicking pheochromocytoma. Am J Clin Pathol 104(4):382–390, 1995.PubMedGoogle Scholar
  18. 18.
    Haak HR, Fleuren GJ. Neuroendocrine differentiation of adrenocortical tumors. Cancer 75(3):860–864, 1995.PubMedCrossRefGoogle Scholar
  19. 19.
    Clarke MR, Weyant RJ, Watson CG, Carty SE. Prognostic markers in pheochromocytoma. Hum Pathol 28:522–526, 1998.CrossRefGoogle Scholar
  20. 20.
    Pelky TJ, Frierson HF Jr, Mills SE, Stoler MH. The alpha subunit of inhibin in adrenal cortical neoplasia. Mod Pathol 11(6):516–524, 1998.Google Scholar
  21. 21.
    De Krijger RR, Van Der Harst E, Van Der Ham F, Stijnen T, Dinjens WN, Koper JW, Bruining HA, Lamberts SWJ, Bosman FT. Prognostic value of p53, bcl-2, and c-erbB-2 protein expression in phaeochromocytomas. J Pathol 188:51–55, 1999.PubMedCrossRefGoogle Scholar
  22. 22.
    Tartour E, Caillou B, Tenenbaum F, Schröder S, Luciani S, Talbot M, Schlumberger M. Immunohistochemical study of adrenocortical carcinoma. Cancer 73:3296–3303, 1993.CrossRefGoogle Scholar
  23. 23.
    Hage R, Elbers HRJ, de la Riviéra AB, van den Bosch JMM. Neural cell adhesion molecules expression. Clin Invest 114(5):1316–1320, 1998.Google Scholar
  24. 24.
    Christofori G, Semb H. The role of celladhesion molecule E-cadherin as a tumor-suppressor gene. TIBS 24:73–76, 1999.PubMedGoogle Scholar
  25. 25.
    Gupta D, Shidham V, Holden J, Layfield L. Prognostic value of immunohistochemical expression of topoisomerase alpha II, MIB-1, p53, E-cadherin, retinoblastogene protein product, and HER-2/neu in adrenal and extraadrenal pheochromocytoma. Appl Immunohistochem Mol Morphol 8(4):267–274, 2000.PubMedCrossRefGoogle Scholar
  26. 26.
    Khorram-Manesh A, Ahlman H, Jansson S, Wängberg B, Nilsson O, Jakobsson CE, Eliasson B, Lindstedt S, Tisell LE. Adrenocortical carcinoma: surgery and mitotane for treatment and steroid profiles for follow-up. World J Surg 22:605–612, 1998.PubMedCrossRefGoogle Scholar
  27. 27.
    Ahlman H, Khorram-Manesh A, Jansson S, Wängberg B, Nilsson O, Jacobsson CE, Lindstedt S. Cytotoxic treatment of adrenocortical carcinoma. World J Surg 25:927–933, 2001.PubMedCrossRefGoogle Scholar
  28. 28.
    Tischler AS, Sheldon W, Gray R. Immunohistochemical and morphological characterization of spontaneously occurring pheochromocytoma in the aging mouse. Vet Pathol 33:512–520, 1996.PubMedCrossRefGoogle Scholar
  29. 29.
    Kim JB, Islam S, Kim Y, Prudoff RS, Sass KM, Wheelock MJ, Johnson KR. N-cadherin extracellular repeat 4 mediates epithelial to mesenchymal transition and increased motility. J Cell Biol 151:1193–1204, 2000.PubMedCrossRefGoogle Scholar
  30. 30.
    Lambert M, Padilla F, Mége RM. Immobilized dimers of N-cadherin-Fc chimera mimic cadherin-mediated cell contact formation: contribution of both outside-in and insideout signals. J Cell Sci 113:2207–2219, 2000.PubMedGoogle Scholar
  31. 31.
    Zeromski J, Lawniczak M, Golusinski P. Expression of CD56/N-CAM antigen and some other adhesion molecules in various human endocrine glands. Folia Histochem Cytobiol 36(3):119–125, 1998.PubMedGoogle Scholar
  32. 32.
    Meyer MB, Bastholm L, Nielsen MH, Elling F, Rygaard J, Chen W, Öbrink B, Bock E, Edvardsen K. Localization of NCAM on NCAM-B-expressing cells with inhibited migration in collagen. APMIS 103:197–208, 1995.PubMedCrossRefGoogle Scholar
  33. 33.
    Barshack I, Goldberg I, Nass D, Olchovsky D, Kopolovic J. CD44 expression in normal adrenal tissue and adrenal tumors. J Clin Pathol 51:52–54, 1998.PubMedCrossRefGoogle Scholar
  34. 34.
    Iino K, Sasano H, Yabuki N, Oki Y, Kikuchi A, Yoshimi T, Nagura H. DNA topoisomerase II alpha and Ki-67 in human adrenocortical neoplasms: a possible marker of differentiation between adenomas and carcinomas. Mod Pathol 10(9):901–907, 1997.PubMedGoogle Scholar
  35. 35.
    Nakazumi H, Sasano H, Iino K, Ohashi Y, Orikasa S. Expression of cell cycle inhibitor p27 and Ki-67 in human adrenocortical neoplasms. Mod Pathol 11(12):1165–1170, 1998.PubMedGoogle Scholar
  36. 36.
    Sasano H, Imatani A, Shizawa S, Suzuki T, Nagura H. Cell proliferation and apoptosis in normal and pathologic human adrenal. Mod Pathol 8(1):11–17, 1995.PubMedGoogle Scholar
  37. 37.
    Key G, Becker MHG, Baron B, Duchrow M, Schlüter C, Flad HD, Gerdes J. New Ki-67-equivalent murine monoclonal antibodies (MIB1–3) generated against bacterially expressed parts of the Ki-67 cDNA containing three 62 base pair repetitive elements encoding for the Ki-67 epitope. Lab Invest 68(6):629–636, 1993.PubMedGoogle Scholar
  38. 38.
    Nagura S, Katoh R, Kawaoi A, Kobayashi M, Obara T, Omata K. Immunohistochemical estimations of growth activity to predict biological behavior of pheochromocytoma. Mod Pathol 12(12):1107–1111, 1999.PubMedGoogle Scholar
  39. 39.
    Vargas MP, Vargas HI, Kleiner DE, Merino MJ. Adrenocortical neoplasm: role of prognostic markers MIB-1, P53, and RB. Am J Surg Pathol 21(5):556–562, 1997.PubMedCrossRefGoogle Scholar
  40. 40.
    Edgren M, Eriksson B, Oberg K. Biological characteristics of adrenocortical carcinomas: a study of p53, IGF, EGF-r, Ki-67 and PCNA in 17 adrenocortical carcinomas. Anticancer Res 17(2B):1303–1309, 1997.PubMedGoogle Scholar

Copyright information

© Humana Press Inc 2002

Authors and Affiliations

  • Amir Khorram-Manesh
    • 1
  • Håkan Ahlman
    • 1
  • Svante Jansson
    • 1
  • Ola Nilsson
    • 1
  1. 1.Lundberg Laboratory for Cancer Research, Departments of Surgery and PathologySahlgrenska University HospitalGöteborgSweden

Personalised recommendations